A real life study to determine the safety of the Fluquadri vaccine (Influenza vaacine) during routine clinical practice in children who are 6 months to 35 months of age in India
Phase 4
- Conditions
- Health Condition 1: B998- Other infectious disease
- Registration Number
- CTRI/2024/06/068442
- Lead Sponsor
- Sanofi Healthcare India Pvt. Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Participants aged 6 to 35 months, who have received either 1 or 2 doses (depending on previous influenza vaccination status) of the 0.5ml Quadrivalent Inactivated Influenza Vaccine (split virion) in routine clinical care.
- Written informed consent will be taken prior to recruitment of participant.
Exclusion Criteria
None
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method